InMode Ltd
$ 14.62
1.04%
26 Dec - close price
- Market Cap 944,345,000 USD
- Current Price $ 14.62
- High / Low $ 14.64 / 14.36
- Stock P/E 6.28
- Book Value 9.94
- EPS 2.38
- Next Earning Report 2026-02-03
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.09 %
- ROE 0.26 %
- 52 Week High 19.85
- 52 Week Low 13.14
About
InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary RF-assisted lipolysis and deep subdermal fractional RF technologies. The company is headquartered in Yokneam, Israel.
Analyst Target Price
$16.25
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-05 | 2025-07-30 | 2025-04-28 | 2025-02-04 | 2024-10-30 | 2024-08-01 | 2024-05-02 | 2024-02-13 | 2023-11-02 | 2023-07-27 | 2023-05-02 | 2023-02-14 |
| Reported EPS | 0.38 | 0.47 | 0.31 | 1.14 | 0.7 | 0.34 | 0.32 | 0.71 | 0.61 | 0.72 | 0.52 | 0.78 |
| Estimated EPS | 0.35 | 0.41 | 0.35 | 0.47 | 0.61 | 0.38 | 0.41 | 0.67 | 0.63 | 0.66 | 0.48 | 0.69 |
| Surprise | 0.03 | 0.06 | -0.04 | 0.67 | 0.09 | -0.04 | -0.09 | 0.04 | -0.02 | 0.06 | 0.04 | 0.09 |
| Surprise Percentage | 8.5714% | 14.6341% | -11.4286% | 142.5532% | 14.7541% | -10.5263% | -21.9512% | 5.9701% | -3.1746% | 9.0909% | 8.3333% | 13.0435% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-03 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: INMD
2025-12-28 13:09:35
InMode Ltd. (NASDAQ:INMD) shareholders have experienced a significant 59% loss over the past three years, despite the company's earnings per share (EPS) improving by 3.5% annually during the same period. This disparity suggests that earlier growth expectations for InMode's stock might have been overly optimistic and have since been moderated. The article notes a 7.6% annual revenue decline over three years as a possible contributing factor to the share price fall, questioning the sustainability of EPS growth without revenue expansion.
2025-12-24 13:09:25
Lind Value II ApS significantly reduced its stake in InMode Ltd. (NASDAQ:INMD) by 35.0% in Q3 2025, selling 95,228 shares and bringing its total holding to 176,940 shares, valued at $2.64 million. Despite this reduction, other institutional investors like Squarepoint Ops, Tower Research Capital, and HRT Financial increased their positions, and new stakes were taken by Hudson Bay and Topline Capital Management. Analysts currently have a consensus "Hold" rating for InMode with a target price of $16.60, as the stock trades near $14.37.
2025-12-21 07:08:58
This article provides a price-driven insight for Inmode Ltd. (NASDAQ: INMD), highlighting stable neutral readings in shorter horizons which could signal an easing of a long-term weak bias. It details an exceptional 39.0:1 risk-reward setup targeting an 11.3% gain versus 0.3% risk, along with specific institutional trading strategies for position trading, momentum breakout, and risk hedging. The analysis includes multi-timeframe signal analysis with support and resistance levels.
2025-12-19 10:08:57
Squarepoint Ops LLC significantly increased its stake in InMode Ltd. (INMD) by 92.9% in Q2, bringing their total holding to 143,758 shares valued at approximately $2.08 million. This move is part of a broader trend of institutional investors boosting their positions in InMode, with institutions now owning about 68.04% of the company. Despite sustained hedge fund interest, analysts currently rate InMode as a "Hold" with an average target price of $16.60, as the stock trades near $14.56.
2025-12-17 03:19:00
Canaccord Genuity has maintained a Hold recommendation for InMode (INMD), with an analyst price forecast suggesting an 18.34% upside to $17.14/share. The company is projected to see a significant 84.29% increase in annual revenue to $672MM and a non-GAAP EPS of $3.45. Institutional ownership in INMD stands at 41,373K shares held by 331 funds, despite a slight decrease in the last quarter.
2025-12-15 08:08:43
InMode (NASDAQ: INMD) stock appears undervalued with strong fundamentals, including robust gross margins and a substantial net cash position, despite a recent 13.1% decline over the past year. However, revised lower revenue guidance for 2025 and weaker demand for aesthetic treatments in North America introduce caution for near-term investors. Growth opportunities lie in international expansion and new product launches, but competition and economic sensitivity pose risks.
